PDS Biotechnology Corp (PDSB)
3.83
-0.19
(-4.73%)
USD |
NASDAQ |
May 09, 16:00
3.88
+0.05
(+1.31%)
Pre-Market: 09:25
PDS Biotechnology Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 0.275M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 29.11M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.028M |
| September 30, 2017 | -0.0551M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.0164M |
| March 31, 2017 | -0.0893M |
| December 31, 2016 | -0.3473M |
| September 30, 2016 | -0.1441M |
| June 30, 2016 | -0.118M |
| March 31, 2016 | -0.0773M |
| December 31, 2015 | -0.5057M |
| September 30, 2015 | -0.3523M |
| June 30, 2015 | -0.3611M |
| March 31, 2015 | -0.0861M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
0.275M
Maximum
Dec 2019
0.0917M
Average
--
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Syros Pharmaceuticals Inc | 1.522M |
| PAVmed Inc | -0.183M |
| Altimmune Inc | -7.959M |
| Regeneron Pharmaceuticals Inc | -1.687B |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.457M |
| Cash from Financing (Quarterly) | 10.77M |
| Free Cash Flow | -33.64M |
| Free Cash Flow Per Share (Quarterly) | -0.2671 |
| Free Cash Flow Yield | -28.38% |